In a previous post, I suggested a memory exercise based on mentally composing a two-act play and incorporating the items one wishes to memorize. Some readers objected to the additional requirement of ...

Maryland has become the first state in the U.S. to ban stores from engaging in dynamic pricing, a controversial practice gaining traction at retailers nationwide. Gov. Wes Moore first introduced the ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

On Tuesday, OpenAI introduced dynamic visual explanations, a new ChatGPT feature that allows users to see how formulas, variables, and mathematical relationships change in real time. Instead of just ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

The rumored touchscreen OLED MacBook Pro that Apple has in development will adopt the iPhone's Dynamic Island and a hole-punch camera, reports Bloomberg. The ‌Dynamic Island‌ will replace the notch, ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...